Stocktoria
LeonaBio, Inc. LONA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-09-18
LeonaBio, Inc. financials (annual)
Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| R&D expense | $17.5M | $70.7M | $93.8M | $61.5M | $42.8M | $13.3M | $3.8M |
| Operating income | -$102.3M | -$100.9M | -$125.5M | -$104.0M | -$64.0M | -$20.0M | -$5.4M |
| Interest expense | — | — | — | — | $3,000 | $367,000 | $346,000 |
| Income tax | $0 | — | — | — | — | — | — |
| Net income | -$105.6M | -$96.9M | -$117.7M | -$95.6M | -$54.9M | -$20.0M | -$5.2M |
| EPS (diluted) | $-24.70 | $-25.19 | $-3.09 | $-2.53 | $-1.49 | — | — |
| Operating cash flow | -$45.7M | -$97.2M | -$100.8M | -$72.5M | -$43.1M | -$24.1M | -$3.7M |
| Free cash flow | — | -$97.2M | -$101.1M | -$73.6M | -$44.7M | -$26.4M | — |
| Cash & equivalents | $69.3M | $48.4M | $90.6M | $96.0M | $110.5M | $60.6M | $2.1M |
| Total assets | $92.2M | $58.8M | $160.2M | $258.2M | $332.0M | $279.6M | $2.2M |
| Total liabilities | $64.4M | $13.9M | $30.1M | $23.0M | $10.9M | $5.3M | $4.9M |
| Shareholders' equity | $27.8M | $44.8M | $130.2M | $235.1M | $321.1M | $274.3M | -$19.7M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.